Running a CGON wheel strategy lets you generate consistent premium income on Cg Oncology Inc while setting your own entry and exit prices on the underlying. Cg Oncology Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own CGON, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best CGON wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on CGON, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable CGON wheel from a losing one.
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the CGON wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your CGON wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
